Published data indicate a significant increase in ovarian hyperstimulation syndrome
globally. The occurrence of approximately three maternal deaths per 100 000 stimulated …

BACKGROUND GnRH agonist (GnRHa) triggering has been shown to significantly reduce
the occurrence of ovarian hyperstimulation syndrome (OHSS) compared with hCG …

OBJECTIVE: To reevaluate ovarian hyperstimulation syndrome (OHSS) prevention
techniques and provide a classification system for grading OHSS and evidence-based …

STUDY QUESTION Is the risk of severe ovarian hyperstimulation syndrome (OHSS) similar
in a short GnRH antagonist and long GnRH agonist protocol in first cycle IVF/ICSI patients …

OBJECTIVE: To determine the incidence of ovarian hyperstimulation syndrome (OHSS) in a
large series of GnRH antagonist–stimulated cycles and to assess the predictive value of E2 …

BACKGROUND Anti-Müllerian hormone (AMH) is reported to be a reliable marker of the
ovarian response to controlled ovarian stimulation (COS). The objective of this study is to …

Objective To identify, appraise and summarize the current evidence regarding the
pathophysiology, staging, prediction and prevention of ovarian hyperstimulation syndrome …

STUDY QUESTION Is it possible to define a set of performance indicators (PIs) for clinical
work in ART, which can create competency profiles for clinicians and for specific clinical …

Clinical trials testing infertility treatments often do not report on the major outcomes of
interest to patients and clinicians and the public (such as live birth) nor on the harms …

INTRODUCTION: In a randomized controlled trial, we assessed whether pregnancy
outcome would be improved by extending embryo culture to day 5 and transferring a …